| Company Name: | Amarin Corp PLC | | | Ticker Symbol: | AMRN | | CIK Number: | 0000897448 | | WWW Address: | http://www.amarincorp.com |
| CEO: | Mr. John F. Thero | | No. of Employees: | 215 |
| Common Issue Type: | CS | | Business Description: | Amarin Corporation PLC is a biopharmaceutical company that commercializes and develops therapeutics to improve cardiovascular health.
|
| | | Industry Information: | DRUGS - Drug Manufacturers - Other [more like this] |
| | Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 17.23 |  -0.03 | 17.14 | 17.2 | 17.55 | 17.24 | 17.19 | 5966554 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 5,621.9 | 326.3 | 0.00 | -0.25 | 0.00 | 0.0 | 0.0 | 23.34 - 2.35 |
| | KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 17.21 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 5,621.9 | mil |
| Latest Shares Outstanding | 326.3 | mil |
| Earnings pS (EPS) | -0.25 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | | % |
| Revenue per Employee | 751,469 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 0.0 | mil |
| Float as % of Shares Outstanding | | % |
| Foreign Sales | | mil |
| Domestic Sales | | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 0.70 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.30 | % |
| Gross Profit Margin | 0.0 | % |
| EBITDA Margin | 0.0 | % |
| Pre-Tax Profit Margin | 0.0 | % |
| Assets Turnover | 0.0 | % |
| Return on Assets (ROA) | 0.0 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | 0.0 | % |
| Current Ratio | | |
| Leverage Ratio (Assets/Equity) | | |
| Interest Cover | | |
| Total Debt/Equity (Gearing Ratio) | | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | 0.14 | $ |
| Cash pS | 0.00 | $ |
| Book-Value pS | -0.23 | $ |
| Tangible Book-Value pS | -0.30 | $ |
| Cash Flow pS | -0.23 | $ |
| Free Cash Flow pS | -0.23 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | | |
| Price/Tangible Book Ratio | 0.00 | |
| Price/Cash Flow | | |
| Price/Free Cash Flow | | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | | | | | PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.8 | | 11,181,312 | |
| 4 Weeks | 18.92 | 11.75 | 12.55 | 37.5 | | 9,205,591 | 174,906,234 |
| 13 Weeks | 23.34 | 11.75 | 19.79 | -12.8 | | 10,317,331 | 639,674,571 |
| 26 Weeks | 23.34 | 2.35 | 2.83 | 509.9 | | 11,907,566 | 1,500,353,391 |
| 52 Weeks | 23.34 | 2.35 | 4.04 | 327.2 | | 7,165,136 | 1,805,614,501 |
| YTD | 18.92 | 11.75 | - | 32.9 | | 10,124,695 | 141,745,735 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 16.93 | 16.72 | 16.21 | 11.18 | 8.96 | 0.00 | 0.00 |
| | | | GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | | 0.0 | |
| Income | | 0.0 | |
| Dividend | | 0.0 | |
| Capital Spending | | NA | |
| R&D | 34.92 | NA | 42.07 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 0.0 | 0.0 | 0.0 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | 0.24 | 0.24 | -0.71 |
| | | | SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 27.69 |
| Current Ratio | 1.4 |
| Quick Ratio (Acid Test) | 1.1 |
| Liquidity Ratio (Cash) | 1.36 |
| Receivables Turnover | 5.5 |
| Average Collection Period | 65 |
| Working Capital/Equity | 0.0 |
| Working Capital pS | 0.15 |
| Cash-Flow pS | -0.12 |
| Free Cash-Flow pS | -0.12 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 14.80 |
| Financial Leverage Ratio (Assets/Equity) | 0.0 |
| Debt Ratio | 75.9 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 356.0 |
| LT Debt/Total Liabilities | 81.4 |
| Interest Cover | -4.6 |
| Interest/Capital Invested | 18.40 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 0.00 |
| Tobin's Q Ratio | 34.79 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | -129.11 |
| Enterprise Value (EV)/Free Cash Flow | -172.90 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 0.00 |
| Price/Book Ratio - LTM | |
| Price/Cash Flow Ratio | |
| Price/Free Cash Flow Ratio - LTM | |
| Price/Sales Ratio | 0.00 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 7.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 0.00 |
| Tangible Book Value pS - LTM | -0.30 |
| Book Value pS - LTM | -0.23 |
| Capital Invested pS | 0.10 |
| Cash pS - LTM | 0.00 |
| Cash Flow pS - LTM | -0.23 |
| Free Cash Flow pS - LTM | -0.23 |
| Earnings pS (EPS) | -0.25 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -18.14 |
| Free Cash Flow Margin 5YEAR AVG | -206.56 |
| Net Profit Margin | -0.4 |
| Net Profit Margin - 5YEAR AVRG. | |
| Equity Productivity | -2.02 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | |
| Capital Invested Productivity | 5.46 |
| Return on Capital Invested (ROCI) | 0.0 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | |
| Assets Productivity | 1.10 |
| Return on Assets (ROA) | -0.4 |
| Return on Assets (ROA) - 5YEAR AVRG. | |
| Gross Profit Margin | 0.0 |
| Gross Profit Margin - 5YEAR AVRG. | |
| EBITDA Margin - LTM | 0.0 |
| EBIT Margin - LTM | 0.0 |
| Pre-Tax Profit Margin | -2.0 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | |
| Effective Tax Rate | -3.2 |
| Effective Tax Rate - 5YEAR AVRG. | -1.6 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 688,657 |
| Revenue per Employee | 751,469 |
| Net Income per Employee | |
| Average Collection Period | 688,657 |
| Receivables Turnover | 5.5 |
| Day's Inventory Turnover Ratio | |
| Inventory Turnover | 1.8 |
| Inventory/Sales | 16.7 |
| Accounts Payble/Sales | 14.16 |
| Assets/Revenue | 0.91 |
| Net Working Capital Turnover | 4.05 |
| Fixed Assets Turnover | 22.21 |
| Total Assets Turnover | 1.1 |
| Revenue per $ Cash | 2.46 |
| Revenue per $ Plant | 6468.00 |
| Revenue per $ Common Equity | 0.00 |
| Revenue per $ Capital Invested | 5.46 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 74.3 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
| Research & Devlopment (R&D) as % of Revenue | 26.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 26.0 |
|
|  
| | |  |  | | |
